Trial intelligence / Profile preview

Effect of single-dose sitagliptin on islet function after a standardized mixed meal in men with type 2 diabetes

2012-005660-98Phase 4Active

Sponsor
Lund University
Start
Feb 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, single-arm trial of sitagliptin in type 2 diabetes mellitus (T2DM), sponsored by Lund University. Primary endpoint: Area under the 180-minute curve for plasma insulin concentrations. Started Feb 2013; status: active.

02

Drugs

sitagliptin
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on 2012-005660-98.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-005660-98.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call